跳至主要内容
临床试验/CTRI/2024/05/066800
CTRI/2024/05/066800尚未招募2 期

A Single Arm Clinical Study To Evaluate The Efficacy Of Duralabhadi Churna In The Management Of Vatik Kasa In Children. - NI

Dr Rukhsana Sheikh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)The patients having minimum 2 symptoms of Vatik Kasa are as follows-
  • 1.The frequency of Kasa vega (Dry Cough)
  • 2.Udarparshwa Shula (chest pain)
  • 3.Swarbheda (Hoarseness of Voice)
  • 4.Shukpurna Galasyata (Feeling Of Thorn Pricking in the Throat)
  • 2) Patients between the ages of 1 year and 12 year.
  • 3) The patients whose parents are ready to participate in the clinical trial by giving informed written consent.

排除标准

  • 1)Patients of other types of kasa (pittaj, kaphaj,
  • kshayaj, kshataj)
  • 2)Patients having life threatening illness and who is bed ridden.
  • 3)Patients having any congenital respiratory and
  • GIT abnormality.
  • 4)Patients who require surgical management. 5)Patients having concomitant other systemic disorders like T.B., Bronchiolitis, Asthma, Pneumonia, Bronchiectasis, Lung abscess, Foreign body, pertussis etc.
  • 6)Patient having complaint of fever or recent history of fever .

研究者

发起方
Dr Rukhsana Sheikh

相似试验